Genedrive (GB:GDR) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Genedrive PLC has released its 2024 Annual Report and announced the upcoming Annual General Meeting on December 30, 2024. The company, a leader in pharmacogenetic testing, continues to innovate with its Genedrive® MT-RNR1 and CYP2C19 ID Kits, enhancing personalized medicine and improving patient outcomes in emergency care. The company is focused on growth through market expansion and strategic acquisitions.
For further insights into GB:GDR stock, check out TipRanks’ Stock Analysis page.